FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Specialty Medicine Compounding Pharmacy Flucon/Gent* Recall

FLUCON/GENT* (fluconazole and gentamicin) 200 mg/480 mg/1 L SOLUTION, Rx only, Specialt…

Specialty Medicine Compounding Pharmacy · South Lyon, MI

Risk level
Class II
Reported by FDA
Jan 22, 2014
Recall ID
D-420-2014
Check your lot numberHow we source this data

Summary

Specialty Medicine Compounding Pharmacy recalled Flucon/Gent* starting Oct 19, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-420-2014 on Jan 22, 2014. Reason: Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Product description

FLUCON/GENT* (fluconazole and gentamicin) 200 mg/480 mg/1 L SOLUTION, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178

Lot numbers, UPCs & expiration codes

All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 10042013@7

Where it was sold

Hospitals, clinics, physicians, and patients in the Michigan area only.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-420-2014
Classification
Class II
Status
Terminated
Recall initiated
Oct 19, 2013
FDA report date
Jan 22, 2014
Quantity
700 mL
Recall type
Voluntary: Firm initiated
Recalling firm
Specialty Medicine Compounding Pharmacy

Original FDA data

Every field from FDA enforcement report D-420-2014, exactly as published.

Show all FDA fields
City
South Lyon
State
MI
Status
Terminated
Country
United States
Event ID
66566
Address
350 S Lafayette St
Code information
All unexpired lots, manufactured and distributed between 07/01/2013 and 10/19/2013; including Lot #: 10042013@7
Postal code
48178-1814
Report date
Jan 22, 2014
Product type
Drugs
Recall number
D-420-2014
Classification
Class II
Recalling firm
Specialty Medicine Compounding Pharmacy
Product quantity
700 mL
Termination date
Sep 22, 2014
Reason for recall
Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
Voluntary / mandated
Voluntary: Firm initiated
Product description
FLUCON/GENT* (fluconazole and gentamicin) 200 mg/480 mg/1 L SOLUTION, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
Distribution pattern
Hospitals, clinics, physicians, and patients in the Michigan area only.
Recall initiation date
Oct 19, 2013
Initial firm notification
Press Release
Center classification date
Jan 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-420-2014, published Jan 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls